Summit Therapeutics PLC (NASDAQ:SMMT, LON:SUMM) said on Friday its chief financial officer Erik Ostrowski will present at the Canaccord Genuity Growth Conference, 11 August at 1:30pm EDT in Boston.
The London- and New York-listed drug discovery and development company seeks to advance therapies for Duchenne muscular dystrophy and Clostridium difficile infection.
Summit’s ADRs were unchanged at $7.05 on Friday.